Determination of Blood NOTCH3 Extracellular Domain and Jagged-1 Levels in Healthy Subjects
- PMID: 36142458
- PMCID: PMC9505916
- DOI: 10.3390/ijms231810547
Determination of Blood NOTCH3 Extracellular Domain and Jagged-1 Levels in Healthy Subjects
Abstract
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common genetic disorder among those responsible for hereditary strokes, and it is caused by a mutation in the NOTCH3 gene on chromosome 19. Blood biomarkers related to the Notch signaling pathway have not been investigated extensively in CADASIL. In this study, we measured the serum and plasma levels of NOTCH3 extracellular domain (N3ECD) and its ligand, Jagged-1, in 279 healthy subjects. The levels of N3ECD and Jagged-1 showed significant correlations in both serum (p < 0.0001, r = 0.2681) and plasma (p < 0.0001, r = 0.4065). The N3ECD levels were significantly higher in the serum than in plasma and tend to increase with age. In contrast, there was no significant difference between the serum and plasma levels of Jagged-1 levels. To summarize, we were able to measure N3ECD and Jagged-1 protein levels in healthy human serum and plasma. Taken together, our findings provide the basis for further studies investigating the clinical use of blood N3ECD and Jagged-1 levels for CADASIL and other Notch signaling-related diseases.
Keywords: CADASIL; Jagged-1; NOTCH3 extracellular domain; blood marker; plasma; serum.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Transendocytosis is impaired in CADASIL-mutant NOTCH3.Exp Neurol. 2012 Jan;233(1):303-11. doi: 10.1016/j.expneurol.2011.10.020. Epub 2011 Oct 28. Exp Neurol. 2012. PMID: 22079830
-
CADASIL-associated Notch3 mutations have differential effects both on ligand binding and ligand-induced Notch3 receptor signaling through RBP-Jk.Exp Cell Res. 2004 Oct 1;299(2):454-64. doi: 10.1016/j.yexcr.2004.06.004. Exp Cell Res. 2004. PMID: 15350543
-
Progress to Clarify How NOTCH3 Mutations Lead to CADASIL, a Hereditary Cerebral Small Vessel Disease.Biomolecules. 2024 Jan 18;14(1):127. doi: 10.3390/biom14010127. Biomolecules. 2024. PMID: 38254727 Free PMC article. Review.
-
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) associated with a novel C82R mutation in the NOTCH3 gene.J Alzheimers Dis. 2015;43(2):363-7. doi: 10.3233/JAD-141218. J Alzheimers Dis. 2015. PMID: 25096610
-
[Study of the familiar form of vascular dementia (CADASIL)].Nihon Shinkei Seishin Yakurigaku Zasshi. 2007 Jun;27(3):141-5. Nihon Shinkei Seishin Yakurigaku Zasshi. 2007. PMID: 17633526 Review. Japanese.
Cited by
-
Potential biomarkers for cerebral small vessel disease with cognitive impairment: a systematic review and meta-analysis.Front Aging Neurosci. 2025 Jan 7;16:1475571. doi: 10.3389/fnagi.2024.1475571. eCollection 2024. Front Aging Neurosci. 2025. PMID: 39839309 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous